Skip to main content
. 2020 Dec 14;10:21881. doi: 10.1038/s41598-020-78930-x

Figure 1.

Figure 1

The experimental scheme. On postnatal day 12 (P12), mice underwent permanent middle cerebral artery occlusion (MCAO). Two days after the injury (P14), they were administered vehicle, umbilical-cord-blood-derived CD34+ cells (CD34+), or umbilical-cord-derived mesenchymal stem/stromal cells (MSCs) intravenously (i.v.). At P15, brain samples were collected. For metabolomic analysis, brain extracts from the injured hemispheres were analyzed by CE-TOF MS, and coronal brain sections from another cohort of mice were subjected to MS imaging.